Longtime CEO at Bay Area's OncoMed Steps Down Post author:Sam Post published:January 4, 2018 Post category:BioPharma Board of Directors has initiated search to identify successor. Source: BioSpace You Might Also Like INVO Bioscience Appoints Renowned Fertility Specialist To Its Board Of Directors April 10, 2017 Aimmune Presents European Phase III PALISADE Screening Data At 2017 European Academy of Allergology and Clinical Immunology (EAACI) Congress June 19, 2017 Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
Aimmune Presents European Phase III PALISADE Screening Data At 2017 European Academy of Allergology and Clinical Immunology (EAACI) Congress June 19, 2017
Envisia Therapeutics Releases Interim ENV515 (Travoprost XR) Phase II Data Demonstrating 11-Month Duration-Of-Action After A Single Dose In Patients With Glaucoma February 2, 2017
